- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02741531
The Effect of Partial Bladder Filling on Post-operative Time to Void in Minimally Invasive Gynecologic Procedures
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
Patients undergoing laparoscopic/robotic hysterectomy or myomectomy who meet the study criteria will be contacted by the research assistant at a pre-operative visit. The risks and benefits of participation will be explained to them. If they choose to participate they will sign the consent form at that time.
At the time of the surgery, the research coordinator will open a sealed envelope containing the patient's assignment to partial bladder filling or no bladder filling. The research coordinator will then notify the surgeon via secure phone call or secure messaging service and the patient/subject will have their bladder partially filled or completely emptied as relayed to the surgeon at the end of the procedure in the Operating Room, unless there are issues of patient safety or operative complications. In the patients who are chosen for partial bladder filling, the bladder will be back-filled with 150 cc of normal saline and then the Foley catheter will be removed at the end of the procedure. In patients who have no bladder filling, the bladder will be completely emptied and then the Foley catheter will be removed. One of the providers who perform the gynecological surgical procedures will be responsible for back-filling or completely emptying the bladder with the Foley catheter.
The patients will be followed in the PACU to determine the time it takes for them to void. The will also be followed for any complications until they are four weeks post surgery. The electronic medical record will be examined to see if they have any complications reported at their post-operative visits or any readmissions to the hospital.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
District of Columbia
-
Washington, District of Columbia, United States, 20037
- George Washington University Medical Faculty Associates
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Hysterectomy or myomectomy planned for a benign gynecologic reason. (This means that there is no evidence of, or concern for, malignancy in the cervix, uterus, tubes or ovaries. Benign gynecologic reasons to have a hysterectomy include fibroids, abnormal uterine bleeding, endometriosis, and pelvic pain. Benign reason for myomectomy would be fibroids)
- Patient is scheduled to have surgery with one of the minimally invasive gynecologic surgeons at George Washington University Hospital (GWUH)
- Patient is planned for a robotic assisted total laparoscopic hysterectomy (RA-TLH) or a total laparoscopic hysterectomy (TLH) or robotic assisted or laparoscopic myomectomy.
- Patient is capable of informed consent.
- The patient has no baseline urinary disease.
Exclusion Criteria:
- Hysterectomy or myomectomy is indicated for malignancy
- Hysterectomy or myomectomy is not being performed via robotic or laparoscopic method
- Patient is not capable of providing informed consent
- Patient has urinary disease
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Intervention
Patients in this group will have their bladder filled with 150 cubic centimeters (cc) of saline solution prior to being moved to the PACU.
|
Patients in this arm will have their bladders filled with 150 cc of saline solution.
Saline solution will be used to partially fill patients' bladders
|
|
No Intervention: Control
patients in this group will have their bladders drained completely prior to being moved to the PACU as is the current standard of care.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Time to Void
Time Frame: peri-operative
|
the time (in minutes) between when the patient's foley is removed and when the patient is able to void in the PACU.
|
peri-operative
|
Collaborators and Investigators
Sponsor
Publications and helpful links
Study record dates
Study Major Dates
Study Start
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Estimate)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 121536
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hysterectomy
-
Hitit UniversityErol Olcok Corum Training and Research HospitalCompletedHysterectomy (MeSH nr: E04.950.300.399) | Had Undergone a Hysterectomy | Had Not Been Diagnosed With Cancer | After HysterectomyTurkey (Türkiye)
-
Zuyderland Medisch CentrumCatharina Ziekenhuis EindhovenRecruitingHysterectomy | Natural Orifice Transluminal Endoscopic Surgery | Vaginal HysterectomyNetherlands
-
Muğla Sıtkı Koçman UniversityCompletedAbdominal Hysterectomy | Laparoscopic Hysterectomy
-
Sixth Affiliated Hospital, Sun Yat-sen UniversityNot yet recruiting
-
Medical University of South CarolinaRecruiting
-
Memic Innovative SurgeryRecruiting
-
Universita di VeronaCompleted
-
Indiana UniversityCompleted
Clinical Trials on Bladder filled with saline solution
-
Ain Shams UniversityCompletedHypertonic Saline | Distilled Water | Irrigation | Normal Saline | Bladder (Urothelial, Transitional Cell) Cancer | Nonmuscle Invasive Bladder CancerEgypt
-
Hatem AbuHashimUnknown
-
Cedars-Sinai Medical CenterRecruitingStress Urinary IncontinenceUnited States
-
Cairo UniversityCompletedBladder Injury | Accreta, PlacentaEgypt
-
Ideal Implant IncorporatedCompletedBreast ImplantsUnited States
-
Usama Ahmed Elsaeed Salem, MDCompletedPlacenta Accreta Spectrum | Bladder Injury | Cesarean Hysterectomy | Urinary Tract Injury | Abnormal PlacentationEgypt
-
Qilu Hospital of Shandong UniversityNot yet recruitingBladder (Urothelial, Transitional Cell) Cancer
-
Seoul National University HospitalCompletedRetrograde Bladder FillKorea, Republic of
-
University of AarhusCompletedOveractive Bladder | Urinary IncontinenceDenmark
-
Odense University HospitalRecruitingRecurrent Urinary Tract InfectionsDenmark